These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17642210)

  • 1. [Is adjuvant chemotherapy necessary for the peripherally located stage I adenocarcinoma of the lung?].
    Ohta S; Hirose M; Ishibashi H; Muro H
    Kyobu Geka; 2007 Jul; 60(7):519-22; discussion 522-5. PubMed ID: 17642210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
    Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
    Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.
    Shimizu K; Funai K; Sugimura H; Sekihara K; Kawase A; Shiiya N
    Pathol Int; 2013 Apr; 63(4):201-5. PubMed ID: 23692420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.
    Hashizume S; Nagayasu T; Hayashi T; Hidaka S; Tsuchiya T; Tagawa T; Yamasaki N; Furukawa K; Matsumoto K; Miyazaki T
    Lung Cancer; 2009 Sep; 65(3):363-70. PubMed ID: 19157635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic analysis of 57 cases of primary pulmonary mucinous adenocarcinoma].
    Zhang J; Chen C; Zheng H; Chen G
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):66-8. PubMed ID: 19538874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological study of small adenocarcinoma of the lung].
    Higashiyama M; Doi O; Kodama K; Tateishi R
    Kyobu Geka; 1991 Jan; 44(1):33-7. PubMed ID: 2038143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung.
    Shields TW
    Surg Gynecol Obstet; 1983 Aug; 157(2):185-90. PubMed ID: 6346558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage I adenocarcinoma lung cancer.
    Kashiwabara K; Saeki S; Sasaki J; Nomura M; Kohrogi H
    J Thorac Oncol; 2008 Dec; 3(12):1416-20. PubMed ID: 19057266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma.
    Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B;
    Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.
    Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; Decamp MM
    Cancer; 2009 Mar; 115(5):1059-69. PubMed ID: 19152440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.
    Bodendorf MO; Haas V; Laberke HG; Blumenstock G; Wex P; Graeter T
    Lung Cancer; 2009 Apr; 64(1):71-8. PubMed ID: 18790545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
    Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
    Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.
    Tsuchiya T; Akamine S; Muraoka M; Kamohara R; Tsuji K; Urabe S; Honda S; Yamasaki N
    Lung Cancer; 2007 Jun; 56(3):341-8. PubMed ID: 17350137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma.
    Sasada S; Miyata Y; Mimae T; Mimura T; Okada M
    Ann Thorac Surg; 2015 Dec; 100(6):2079-86. PubMed ID: 26298165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung.
    González-Aragoneses F; Moreno-Mata N; Cebollero-Presmanes M; García-Yuste M; Cañizares-Carretero MA; Molins-López-Rodó L; Quevedo-Losada S; Torres-Lanzas J; Alvarez-Fernández E;
    Cancer; 2007 Oct; 110(8):1776-81. PubMed ID: 17724707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of stage IIB lung cancer from the pathological factors].
    Tanaka T; Kaneda Y; Fujita N; Ueda K; Saeki K; Sakano H; Matsuoka T; Sudo M; Hayashi M; Zempo N; Esato K
    Kyobu Geka; 2001 May; 54(5):359-62; discussion 363-5. PubMed ID: 11357296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.